Headlines
- Final Glance: Biotechnology companiesAP(Mon, Jun 17)
- Amgen Xgeva Label ExpandedZacks(Mon, Jun 17)
- American Generics Can't Touch This $8 Billion Drug (Yet)at Motley Fool(Mon, Jun 17)
- Midday Glance: Biotechnology companiesAP(Mon, Jun 17)
- 5 Stocks Raising The Drugs Industry Higherat TheStreet(Mon, Jun 17)
- Huge Upside on Pipeline Strengthat Motley Fool(Mon, Jun 17)
- Early Glance: Biotechnology companiesAP(Mon, Jun 17)
- Today's Market: Biotech And Cable M&A The Big Storiesat Seeking Alpha(Mon, Jun 17)
- Amgen share buybacks, drugs may fuel more stock gains - Barron'sReuters(Sun, Jun 16)
- Taking Care Of Yourself And Your Property Through These Stocksat Seeking Alpha(Sun, Jun 16)
- 3 Winners and 2 Losers From Rigel's Failureat Motley Fool(Sat, Jun 15)
- This Week in Biotechat Motley Fool(Sat, Jun 15)
- This Weekend's Barron's: Barron's Midyear Roundtable ~ Eastman Chemical's Winning Formula ~ Case for Amgen ~ Big Lot's Stock Is a Steal ~ BB&T Banks Is Finally Getting Up to Speedat Barrons.com(Sat, Jun 15)
- [$$] "We Have the Whole Toolbox"at Barrons.com(Sat, Jun 15)
- Johnson & Johnson's Gut Feeling About the Future of Medicineat Motley Fool(Fri, Jun 14)
Press Releases
Reports
- Trading Report for (AMGN). A detailed report, including free correlated market...Stock Traders Daily(Jun 18)
- The Investment Rate - a measure of investment demand.Stock Traders Daily(Jun 18)
- AMGN - Amgen Inc - Upgraded to a Buy - Company Analysis and ASR Ranking ReportAlpha Street Research(Jun 18)
